Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junqi Niu

Showing results (191-200 of 280) with videos related to

Pageof 28
Sort By:
Antimicrobial Agents and Chemotherapy|April 11, 2022
Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Expression Inhibitor GST-HG131 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation TrialXiaojiao Li, Yusi Liu, Hanxin Yao, et al.
Cell Chemical Biology|February 6, 2026
Mechanosensation promotes broad-spectrum antiviral defense through membrane remodelingYuehan Huang, Haoran Guo, Delong Gao, et al.
The Journal of Infectious Diseases|March 27, 2020
Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis BRong Fan, Jie Peng, Qing Xie, et al.
The Journal of Pharmacy and Pharmacology|April 10, 2018
Clinical evaluation of efficacy, tolerability and pharmacokinetics of yimitasvir phosphate in patients infected with hepatitis C virusHong Zhang, Xiaoxue Zhu, Qingmei Li, et al.
Journal of Clinical and Translational Hepatology|April 10, 2025
Prevalence of Hepatitis D Virus Antibody Positivity in Chinese Patients with Chronic Hepatitis B Virus InfectionXieer Liang, Qiaoqiao Chen, Hong Tang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 14, 2024
Safety, Pharmacokinetics and Antiviral Efficacy of Capsid Assembly Modulator Freethiadine in Healthy Volunteers and Chronic Hepatitis B PatientsXiaojiao Li, Jia Xu, Jixuan Sun, et al.
Journal of Autoimmunity|June 6, 2024
Prevalence and clinical profiles of primary sclerosing cholangitis in China: Data from electronic medical records and systematic literature retrievalXiaoqian Xu, Tongtong Meng, Lichen Shi, et al.
Diabetes|October 1, 2015
The Metabolic Regulator Histone Deacetylase 9 Contributes to Glucose Homeostasis Abnormality Induced by Hepatitis C Virus InfectionJizheng Chen, Ning Wang, Mei Dong, et al.
The Lancet. Gastroenterology & Hepatology|January 19, 2026
ALG-000184 (pevifoscorvir sodium) monotherapy in participants with chronic HBV infection: a phase 1, multicentre, randomised, dose escalation trialMan-Fung Yuen, Kosh Agarwal, Alina Jucov, et al.
Journal of Gastroenterology and Hepatology|April 5, 2016
Nationwide survey of specialist knowledge on current standard of care (Peg-IFN/RBV) and barriers of care in chronic hepatitis C patients in ChinaLai Wei, Jie Li, Xizhong Yang, et al.
Pageof 28

Showing results (191-200 of 280) with videos related to

Sort By:
Pageof 28
Antimicrobial Agents and Chemotherapy|April 11, 2022
Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Expression Inhibitor GST-HG131 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation TrialXiaojiao Li, Yusi Liu, Hanxin Yao, et al.
Cell Chemical Biology|February 6, 2026
Mechanosensation promotes broad-spectrum antiviral defense through membrane remodelingYuehan Huang, Haoran Guo, Delong Gao, et al.
The Journal of Infectious Diseases|March 27, 2020
Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis BRong Fan, Jie Peng, Qing Xie, et al.
The Journal of Pharmacy and Pharmacology|April 10, 2018
Clinical evaluation of efficacy, tolerability and pharmacokinetics of yimitasvir phosphate in patients infected with hepatitis C virusHong Zhang, Xiaoxue Zhu, Qingmei Li, et al.
Journal of Clinical and Translational Hepatology|April 10, 2025
Prevalence of Hepatitis D Virus Antibody Positivity in Chinese Patients with Chronic Hepatitis B Virus InfectionXieer Liang, Qiaoqiao Chen, Hong Tang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 14, 2024
Safety, Pharmacokinetics and Antiviral Efficacy of Capsid Assembly Modulator Freethiadine in Healthy Volunteers and Chronic Hepatitis B PatientsXiaojiao Li, Jia Xu, Jixuan Sun, et al.
Journal of Autoimmunity|June 6, 2024
Prevalence and clinical profiles of primary sclerosing cholangitis in China: Data from electronic medical records and systematic literature retrievalXiaoqian Xu, Tongtong Meng, Lichen Shi, et al.
Diabetes|October 1, 2015
The Metabolic Regulator Histone Deacetylase 9 Contributes to Glucose Homeostasis Abnormality Induced by Hepatitis C Virus InfectionJizheng Chen, Ning Wang, Mei Dong, et al.
The Lancet. Gastroenterology & Hepatology|January 19, 2026
ALG-000184 (pevifoscorvir sodium) monotherapy in participants with chronic HBV infection: a phase 1, multicentre, randomised, dose escalation trialMan-Fung Yuen, Kosh Agarwal, Alina Jucov, et al.
Journal of Gastroenterology and Hepatology|April 5, 2016
Nationwide survey of specialist knowledge on current standard of care (Peg-IFN/RBV) and barriers of care in chronic hepatitis C patients in ChinaLai Wei, Jie Li, Xizhong Yang, et al.
Pageof 28